Navigation Links
Contact lenses with circuits, lights a possible platform for superhuman vision
Date:1/17/2008

Movie characters from the Terminator to the Bionic Woman use bionic eyes to zoom in on far-off scenes, have useful facts pop into their field of view, or create virtual crosshairs. Off the screen, virtual displays have been proposed for more practical purposes visual aids to help vision-impaired people, holographic driving control panels and even as a way to surf the Web on the go.

The device to make this happen may be familiar. Engineers at the University of Washington have for the first time used manufacturing techniques at microscopic scales to combine a flexible, biologically safe contact lens with an imprinted electronic circuit and lights.

"Looking through a completed lens, you would see what the display is generating superimposed on the world outside," said Babak Parviz, a UW assistant professor of electrical engineering. "This is a very small step toward that goal, but I think it's extremely promising." The results were presented today at the Institute of Electrical and Electronics Engineers' international conference on Micro Electro Mechanical Systems by Harvey Ho, a former graduate student of Parviz's now working at Sandia National Laboratories in Livermore, Calif. Other co-authors are Ehsan Saeedi and Samuel Kim in the UW's electrical engineering department and Tueng Shen in the UW Medical Center's ophthalmology department.

There are many possible uses for virtual displays. Drivers or pilots could see a vehicle's speed projected onto the windshield. Video-game companies could use the contact lenses to completely immerse players in a virtual world without restricting their range of motion. And for communications, people on the go could surf the Internet on a midair virtual display screen that only they would be able to see.

"People may find all sorts of applications for it that we have not thought about. Our goal is to demonstrate the basic technology and make sure it works and that it's safe," said Parviz, who he
'/>"/>

Contact: Hannah Hickey
hickeyh@u.washington.edu
206-543-2580
University of Washington
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Eye Care Lacking in Many Who Buy Contact Lenses Online
2. Contact lenses purchased over Internet may place individuals at risk for harmful eyecare practices
3. Contact Lens Shift Can Compromise Vision of People with Astigmatism with the Blink of an Eye
4. ECO2 Plastics to File for FDA Approval for Food-Contact Applications
5. Worlds First Non-Contact Thermometer for Children Now Available at Walgreens Nationwide
6. ACUVUE(R) 2 COLOURS(R) Brand Contact Lenses Launches Virtual Eye Makeover Tool
7. ILC Dover Launches Revolutionary ArmorFlex (R) Pharmaceutical Product Contact Film
8. Presentation at Bio Contact Quebec 2007
9. Service-to-Sales Transformation at Contact Centers Hinges on Soft Skills
10. Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities
11. Other highlights in the Jan. 8 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Contact lenses with circuits, lights a possible platform for superhuman vision
Contact lenses with circuits, lights a possible platform for superhuman vision
(Date:12/1/2009)... Pilots will enable local organizations to t...er for consumers who lack access , ...men Fund, a nonprofit venture firm addressing pove...it has selected four organizations in Kenya to con...r transportation and storage. , , ,The pilot progr...
(Date:12/1/2009)..., LONDON, Dec. 1 Lucrative opportu...s patient monitoring devices market, particularly ...his segment is growing at a rapid pace. The primar...s among an ageing population about devices that he...erly prefer to age at home - a trend supported by ...
(Date:12/1/2009)... Dec. 1 /PRNewswire/ - Sentinelle Medical Inc., a ...vanced visualization software, extends its line of...gical Society of North America (RSNA) annual meeti... Hall A). ,, With the unique Vanguard(R) patien...metry(TM), Sentinelle,s line of breast coils are r...
(Date:12/1/2009)... NYC based physician Dr. Michael Aziz announ...;The Perfect 10 Diet: 10 Key Hormones that Hold th..." (Source books Jan. 2110). The book deliver...pular diets disturb hormones, and promises a drama...alancing hormones. , New ...
(Date:12/1/2009)... Amadeus will operate as a division of Xybio...olls, NJ (PRWEB) December 1, 2009 -- Xybion Corpor...quisition of all operating assets of Quebec City b...t of enterprise governance, risk, compliance and q..., a corporate performance management organization ...
Breaking Medicine News(10 mins):Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 2Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 3Health News:Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges 4Health News:Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan 2Health News:Ageing Demographic Boosts Uptake of Wireless Patient Monitoring Devices Across Europe, Finds Frost & Sullivan 3Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 2Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 3Health News:Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books 2Health News:Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books 3Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 2Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 3
...d's loss to Argentina in a World Cup match in 1998...ttack rates by 27 per cent. The fact that extreme ...ulnerable people is known to almost everyone.Howev...e that hospital admissions for heart attack, stro...
...is received approval from the Food and Drug Admini...nkiller, which will be used to relieve post-operat...vartis facility at Puerto Rico //is the result of ...ties. The marketing campaign for the drug was...
... fish at least once a month can minimise the risk ...d researchers. Around 607 participants deve...w study involving more than 43,005 men aged 39 to ...ere confirmed as hemorrhagic stroke, caused by a l...
...chers at the Medical college of Wisconsin have rec...otective reflexes in the throat area. A one-way va...hroat and smoking causes damage to the// pharyngog...mokers were tested by imaging the relex area befor...
...ing to a recent study researchers have observed th...en though painful, is the best way forward in peri...hose aged 55// or over will be affected by periphe... this situation, you would think walking would be ...
... who are specialzed with specific skills do home c...sease. Chronic bronchitis and emphysema - or chron...ery disabling, because of breathlessness and impai...e home setting cuts costs, re-admission to hospita...
Other Medicine News:
(Date:12/1/2009)...c. 1 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharma...urer and supplier of,modernized traditional Chines...announced that it has received approvals from the ...to produce Pediatric Fever and Cough Oral Liquid i...Z20093060) and Antibacterial,and Anti-inflammatory...
(Date:12/1/2009)...ewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (...eriod has expired under the Hart-Scott-Rodino (HSR...to Vanda,s agreement, dated October 12, 2009, with... effective. Expiration of the waiting period, and...ggers an upfront payment to Vanda of $200 million....
(Date:12/1/2009)...wire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI )...oprietary antibodies for the treatment of cancer, ...ed that Bayer Schering Pharma AG has exercised its...e agreement entered into on January 12, 2009 to de...id tumors. ,, Under the terms of the agreement,...
Breaking Medicine Technology:Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 1Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 2The Advisory Board Company Schedules Second Quarter Conference Call for November 2 2009 59822 1The Advisory Board Company Schedules Second Quarter Conference Call for November 2 2009 59822 2IntraHealth to Lead 24300 Million USAID Project in Global Health Workforce Systems Strengthening 59820 1IntraHealth to Lead 24300 Million USAID Project in Global Health Workforce Systems Strengthening 59820 2
...onstrated Sustained Improvement in Signs and,Sympt...h One-Third,of Patients Achieving Disease Remiss...007 – One-year data show nearly,75 percent o...ritis,(RA) receiving golimumab (CNTO 148) and meth... 20 percent improvement in,arthritis symptoms (ACR...
...ain, June 15, 2007 /PRNewswire-FirstCall/ --,Brist...garding the,efficacy and safety of ORENCIA(R) (aba...vestigational study in children with juvenile,idio...response to,one or more disease-modifying anti- rh... or tumor necrosis factor (TNF) antagonists.,The r...
Other Medicine Technology:Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 2Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 3Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
Medicine Products: